Formulation
Solutions
Formulation Solutions projects span the entire nanoparticle formulation development continuum—from proof-of-concept nanoparticle formulations in early discovery to advancing lead candidate development in scale-up, to optimization and technology transfer of nanoparticle manufacturing processes to CMO/manufacturing sites for cGMP production.
The Precision NanoSystems team uses proprietary NanoAssemblr® microfluidic technology to develop optimized process parameters for the manufacture of lipid or polymer-based nanomedicines that meet target specifications.
• Nanoparticle formulation(s) suitable for proof-of-concept and pre-clinical testing
• Manufacturing support for NanoAssemblr® Ignite and Blaze users
• Tech transfer plan and manufacturing support
to CMO/manufacturing site (for NanoAssemblr® GMP System)
• Standard Operating Protocols for nanoparticle manufacture using the NanoAssemblr® platform and products
• Standard Operating Protocols for downstream (ultrafiltration and diafiltration) processing of nanoparticles
• Analysis of nanoparticle physicochemical and biological properties
The Formulation Solutions team collaborates with customers to develop a well-defined project plan, with identified project deliverables, timeline, and budget.
Formulation Solutions projects span the entire nanoparticle formulation development continuum—from early discovery proof-of-concept nanoparticle formulations to CMO/manufacturing sites for cGMP production.
Talk to a Formulations ExpertPublication - Abstract
July 01, 2020
Journal of Controlled Release
Publication - Abstract
May 08, 2020
Vaccines
Publication - Abstract
April 02, 2020
Journal of Controlled Release
Publication - Abstract
December 31, 2019
Vaccines
Publication - Abstract
May 31, 2019
Vaccine
For more information, please follow the link below for our Formulation Solutions brochure.